HPTN Studies

HPTN research studies are developed by protocol teams that include CTU investigators and recognized experts in HIV prevention. As study protocols are developed, they undergo a rigorous intra- and extra-network review process that ensures compliance with current ethical guidelines and regulatory procedures.

To view detailed information about studies, including performance sites and enrollment figures, select a protocol number from the tables below.  Each Study Protocol is available once version 1.0 is approved and distributed to the performance sites.  The CORE Protocol Contact can provide additional information and materials.

Recent Publications

Momplaisir, F., Hussein, M., Tobin-Fiore, D., Smith, L., Bennett, D., Latkin, C., Metzger, D. S. . Racial Inequities in HIV Prevalence and Composition of Risk Networks Among People Who Inject Drugs in HIV Prevention Trial Network 037. J Acquir Immune Defic Syndr. 2018, 76: 394-401
Dyer, T. V., Khan, M. R., Regan, R., Harawa, N. T., Nelson, L. E., Wilton, L., Wang, L., Peng, L., Ou, S. S., Shoptaw, S. . Differential Patterns of Risk and Vulnerability Suggest the Need for Novel Prevention Strategies for Black Bisexual Men in the HPTN 061 Study. J Acquir Immune Defic Syndr. 2018, 78: 491-498
Salazar-Austin, N., Kulich, M., Chingono, A., Chariyalertsak, S., Srithanaviboonchai, K., Gray, G., Richter, L., van Rooyen, H., Morin, S., Sweat, M., Mbwambo, J., Szekeres, G., Coates, T., Celentano, D., NIMH Project Accept Study Team . Age-Related Differences in Socio-demographic and Behavioral Determinants of HIV Testing and Counseling in HPTN 043/NIMH Project Accept. AIDS Behav. 2018, 22: 569-579
Hill, M. J., Holt, M., Hanscom, B., Wang, Z., Cardenas-Turanzas, M., Latkin, C. . Gender and race as correlates of high risk sex behaviors among injection drug users at risk for HIV enrolled in the HPTN 037 study. Drug Alcohol Depend. 2018, 183: 267-274
Grant RM, Mannheimer S, Hughes JP, Hirsch-Moverman Y, Loquere A, Chitwarakorn A, Curlin ME, Li M, Amico KR, Hendrix C, Anderson PL, Dye BJ, Piwowar-Manning E, McKinstry L, Elharrar V, Stirratt M, Rooney JF, Eshleman SH, Griensven F, Holtz T . A Randomized Open-Label Trial of Daily and Non-daily Oral Pre-exposure Prophylaxis in Men, and Transgender Women, Who Have Sex with Men: HPTN 067/ADAPT. Clin Infect Dis. 2018

Scholars Program

The HIV Prevention Trials Network (HPTN) is proud to offer two scholarship programs for early-career investigators funded through a supplement from the National Institute of Allergy and Infectious Diseases (NIAID). The HPTN Scholars Program now includes two components: a domestic (U.S.) program and an international program. Both programs seek to increase opportunities for scientists from groups under-represented in HIV prevention research.

In the domestic program, successful applicants will be Investigators who have received their terminal degree (MD, Phd, etc). For the international version, current MD, PhD, and MBChB students may apply, along with individuals having already graduated with their terminal degree. In both programs, applicants should desire to work with a mentor scientist in the Network to complete a research project based upon an existing HPTN research study.

Learn more about the Scholars Program